Literature DB >> 20440892

Transplantation: Encouraging results for belatacept immunosuppression in renal transplantation.

Baldo Lucchese.   

Abstract

Year:  2010        PMID： 20440892     DOI： 10.1038/nrneph.2010.46

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  2 in total

1.  A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study).

Authors:  A Durrbach; J M Pestana; T Pearson; F Vincenti; V D Garcia; J Campistol; M del Carmen Rial; S Florman; A Block; G Di Russo; J Xing; P Garg; J Grinyó
Journal:  Am J Transplant       Date:  2010-03       Impact factor: 8.086

2.  A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study).

Authors:  F Vincenti; B Charpentier; Y Vanrenterghem; L Rostaing; B Bresnahan; P Darji; P Massari; G A Mondragon-Ramirez; M Agarwal; G Di Russo; C-S Lin; P Garg; C P Larsen
Journal:  Am J Transplant       Date:  2010-03       Impact factor: 8.086
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.